Colgate-Palmolive (NYSE: CL) → Stocks, dividends, news, and other

Colgate-Palmolive

Free disabling of ads
Dividends News
Favorites

An American company that produces personal care products: soap, oral care products, toothpastes and brushes. It acquired its current name in 1956. The corporation belongs to the category of FMCG-companies that produce consumer fast-use products. Its product range also includes pet food, veterinary drugs, and household chemicals. The corporation has branches and offices in more than 200 countries and owns the rights to the well-known brands Colgate, Palmolive, Mennen, Lady Speed Stick, Softsoap, Protex, Sorriso, etc.

The company has a large number of subsidiaries, but only two of them are officially registered - in the United States and India. In 2004, it began a restructuring process, phasing out some products. During this period, new factories for the production of toothpaste were built in the United States, Mexico and Poland.

The company owns two research centers in new Jersey and Kansas. Their functions are divided: the first is responsible for the development of new personal hygiene products, and the second - animal feed.

  • CL Symbol
  • NYSE Exchange
  • 34,500 Employees
12 rated
  • $79.83, +$0.62 (+0.78%) Previous Close
  • 2,960,926 Previous Volume
  • $58.49 / $80.99 52 week low / high
  • -1.43% Percent off 52 week high
  • 2020-10-20 Updated
  • 2.18% Dividend yield (trailing)
  • 2.20% Dividend yield (forward)
  • 855,071,302 Public float
  • 857,400,000 Outstanding shares
  • 26.62 P/E
  • 67.91 B Market Cap
Free disabling of ads

Financial statements

The information is not 100% up-to-date. There may be errors or something missing. Often something is missing, there are almost no errors, but I can't rule them out. Now I'm looking for a supplier of high-quality information, but so far what I find is expensive (about $ 2000 a year).
2015 2016 2017 2018 2019
Total Revenue 16B 15B 15B 16B 16B
Cost Of Revenue 6.7B 6.1B 6.1B 6.3B 6.4B
Gross Profit 9.4B 9.1B 9.3B 9.2B 9.3B
Research and Development 270M 290M 290M 280M
Selling General and Admin 5.1B 4.9B 5.1B 5.1B
Operating Expense 12B 11B 12B 12B 12B
Operating Income 4B 4B 3.9B 3.9B 3.8B
Other Income Expense Net -1.2B -220M -430M -390M -450M
EBIT 4B 4B 3.9B 3.9B 3.8B
Interest Income 130M 150M 150M 190M 150M
Pretax Income 2.8B 3.7B 3.5B 3.5B 3.3B
Income Tax 1.2B 1.2B 1.3B 910M 770M
Minority Interest 160M 150M 150M 160M 160M
Net Income 1.4B 2.4B 2B 2.4B 2.4B
Net Income Basic 1.4B 2.4B 2B 2.4B 2.4B
2015 2016 2017 2018 2019
Current cash 970M 1.3B 1.5B 730M 880M
Short term investments 100M 71M 18M 10M 23M
Receivables 1.4B 1.4B 1.5B 1.4B 1.4B
Inventory 1.2B 1.2B 1.2B 1.3B 1.4B
Other current assets 450M 370M 390M 410M 430M
Current assets 4.1B 4.3B 4.6B 3.8B 4.2B
Long term investments 54M 42M 42M 46M 54M
Property plant equipment 3.8B 3.8B 4.1B 3.9B 4.3B
Goodwill 2.1B 2.1B 2.2B 2.5B 3.5B
Intangible assets 1.3B 1.3B 1.3B 1.6B 2.7B
Other assets 470M 180M 180M 120M 200M
Total assets 12B 12B 13B 12B 15B
Accounts payable 1.1B 1.1B 1.2B 1.2B 1.2B
Current long term debt 300M 250M
Other current liabilities 1.8B 1.7B 1.8B 1.7B 1.8B
Total current liabilities 3.5B 3.3B 3.4B 3.3B 4B
Long term debt 6.3B 6.5B 6.6B 6.4B 7.8B
Other liabilities 320M 240M 530M 430M 360M
Minority Interest 160M 150M 150M 160M 160M
Total Liabilities 12B 12B 12B 12B 14B
Common stock 890M 880M 870M 860M 850M
Retained earning 19B 20B 21B 22B 23B
Treasury stock 3.9M 3.7M 3.8M 3.9M 3.6M
Capital surplus 1.4B 1.7B 2B 2.2B 2.5B
Shareholder equity -300M -240M -60M -100M 120M
Net tangible assets -6.2B -6.2B -6.3B -7.3B -10B
2015 2016 2017 2018 2019
Net Income 1.4B 2.4B 2B 2.4B 2.4B
Depreciation 450M 440M 480M 510M 520M
Changes in receivables 16M -69M 80M -40M
Changes in inventories -13M -4M -8M -58M -77M
Cash change -120M 350M 220M -810M 160M
Cash flow 2.9B 3.1B 3.1B 3.1B 3.1B
Capital expenditures -690M -590M -550M -440M -340M
Investments -140M 42M 44M -13M -53M
Investing activity other -75M -3M -6M -1M
Total investing cash flows -690M -500M -470M -1.2B -2.1B
Dividends paid -1.4B -1.4B -1.4B -1.4B -1.5B
Net borrowings 420M 160M -29M -180M 1.4B
Other financing cash flows -140M -130M -120M -140M -140M
Cash flow financing -2.3B -2.2B -2.5B -2.7B -870M
Exchange rate effect -110M -64M 87M -16M -7M
Free disabling of ads
Free disabling of ads